The Boeing Company

Boeing's Q2 2026 revenue of $24.56B rose from $22.22B in Q1 2026, a sequential increase of roughly $2.34B, or about +10.5% quarter over quarter. This extends the top-line recovery that management has framed across recent periods, when Q1 2026 revenue of $22.5B was reported up +35% YoY (material event, Boeing 8-K filed April 22, 2026). The sequential growth is the clearest confirmation of the production-led recovery thesis and remains directionally aligned with management's narrative of methodically increasing 737 and 787 production rates.

At the segment level, the current 10-Q reports a single consolidated total of $24.56B for Q2 2026, while Q1 2026 disclosed the discrete mix: Commercial Airplanes $9.20B, Defense, Space & Security $7.60B, Global Services $5.37B, and Other/unallocated $45M, totaling $22.22B. The geographic segmentation shows Commercial Airplanes at $9.16B and Boeing Defense Space Security at $7.60B for Q1 2026, versus $11.03B Commercial and $6.90B Defense in Q3 2025 — illustrating that commercial volume has been the swing factor across the multi-quarter arc, with defense a steadier contributor. The sequential lift in total Q2 revenue is consistent with continued commercial-rate normalization described by management on the prior call.

Margins tell a more cautionary story. Gross profit was $2.41B, a gross margin near 9.8%, down from $2.55B in Q1 2026, where the implied margin was roughly 11.5% — a step-down of roughly 170 basis points sequentially even as revenue grew. This margin compression on higher volume is the single most important disconnect from management's improving-execution narrative this quarter.

Operating income fell to $156M from $448M in Q1 2026, a decline of roughly $292M, or about -65% sequentially, dropping the operating margin from roughly 2.0% to roughly 0.6%. R&D expense rose to $921M from $903M in Q1 2026, a modest sequential increase, and SG&A was $1.43B. The combination of thinner gross margin and higher operating expense is what compressed operating profit despite the revenue tailwind.

Below the line, the net loss widened to -$444M from a near-breakeven -$4M in Q1 2026, and diluted EPS deteriorated to -$0.67 from -$0.11 in Q1 2026. Weighted-average diluted shares were 791M, up modestly from 788M in Q1 2026, reflecting continued dilution following the October 2024 capital raise. Against expectations, the quarter was a clear miss: reported actual EPS of -0.76 versus a -0.34 consensus estimate. This reverses the trajectory of the prior two quarters, which had beaten expectations — Q1 2026 actual -0.2 versus -0.685 estimate and the Q4 2025 print of 9.92 versus a negative estimate — making Q2 the first meaningful downside surprise in the recent recovery sequence.

Cash flow is where the recovery narrative retains its strongest support. Year-to-date operating cash flow turned positive at $1.19B, a marked swing versus the prior-year cash burn and versus the -$179M operating cash flow reported for Q1 2026 alone. Free cash flow remained negative at -$823M year to date after $2.01B of capital expenditure, but that is a narrowing burn relative to the -$1.45B free-cash-flow figure disclosed for Q1 2026. The implication is that the second quarter generated positive free cash flow on a standalone basis, consistent with management's stated goal of a full year of positive cash flow.

On the balance sheet and capital allocation, cash and equivalents were $7.24B, with the quarterly summary noting short-term investments bringing cash plus marketable securities to $20.02B. Long-term debt was $41.34B, down from $44.35B at Q1 2026, a constructive deleveraging step of roughly $3B; the quarterly summary reports a total debt balance of $45.89B including short-term maturities. Dividends paid year to date were only $86M and there were no buybacks, consistent with a balance-sheet-repair posture rather than shareholder returns.

Insider activity was essentially balanced and immaterial over the trailing window, with 24 acquisitions totaling $0.8M and 4 dispositions totaling $1.7M (Form 4 / Section 16), unchanged in character from routine director grants and small officer tax-withholding sales — no signal of a shift in insider positioning versus the prior window (Form 4 / Section 16). Relative to Sentia's own prior assessment, the drift trajectory has eased: the Q1 2026 analysis carried a drift of 74 with a Strengthening status and Cautiously Optimistic tone, and the current read steps that down to reflect the Q2 earnings miss and margin compression while retaining the same core recovery themes around commercial rate ramp, certification timing, cash-flow repair, and defense stabilization.

No direct peer financial comparison is provided in the sourced inputs, so sector positioning is assessed qualitatively: Boeing remains one half of the global large-commercial-aircraft duopoly with a substantial defense franchise, and management has cited a record backlog of nearly $700 billion as the anchor for the recovery. Absent a sourced peer dataset, this analysis does not manufacture cross-company multiples.

The external market view is constructive. Analyst consensus carries a Buy label, with a ratings distribution of 0 Strong Buy, 36 Buy, 13 Hold, 5 Sell and 0 Strong Sell — a heavily Buy-tilted book of 36 buy-side ratings. The consensus price target is 277.14, with a high of 300, a low of 250 and a median of 275. The relatively narrow high-to-low spread suggests the sell-side is broadly aligned on the recovery direction rather than sharply divided, though the 5 Sell ratings signal that skepticism about profitability conversion persists.

Forward consensus estimates imply the market is modeling continued top-line and earnings recovery well beyond the current period: consensus revenue of roughly $133.5B for FY2029 and roughly $145.4B for FY2030, with EPS building to double-digit positive territory over that horizon. These are third-party forward opinions, not Sentia forecasts, and they frame a market expectation of durable normalization rather than the thin, still-loss-making profile of the current quarter.

Geographically and by segment, the data shows commercial volume as the primary swing factor — Commercial Airplanes at $9.16B in Q1 2026 versus $11.03B in Q3 2025, while Defense held steadier at $7.60B versus $6.90B across the same points. This underscores that the market's recovery thesis is disproportionately levered to the pace of 737 and 787 rate ramps and certification timing rather than to defense, which the transcript frames as a demand tailwind.

Relative to the narrative drift, the market's constructive Buy stance and multi-year growth models corroborate management's recovery framing more than they corroborate the current quarter's thin profitability. That tension is precisely why the drift score sits at 66 and the status is Stable rather than Strengthening: the market is pricing the story management is telling, but Q2's earnings miss and margin step-down mean delivered fundamentals lagged that story this quarter. Insider activity offers no offsetting signal, remaining balanced and immaterial (Form 4 / Section 16).